{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:21:19Z","timestamp":1787163679143,"version":"build-2736575974"},"update-to":[{"DOI":"10.1002\/14651858.cd009462","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,11,26]],"date-time":"2016-11-26T00:00:00Z","timestamp":1480118400000}}],"reference-count":87,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009462.pub2","type":"journal-article","created":{"date-parts":[[2016,11,26]],"date-time":"2016-11-26T08:56:48Z","timestamp":1480150608000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Chronotherapy versus conventional statins therapy for the treatment of hyperlipidaemia"],"prefix":"10.1002","volume":"2016","author":[{"given":"Jose Manuel","family":"Izquierdo-Palomares","sequence":"first","affiliation":[{"name":"Servicio Madrile\u00f1o de Salud; Subdirecci\u00f3n General de Farmacia y Productos Sanitarios; Pza. Carlos Tr\u00edas Beltran 7 Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus Maria","family":"Fernandez-Tabera","sequence":"additional","affiliation":[{"name":"Madrid Health Service (Servicio Madrile\u00f1o de Salud); Hospital Management, ColladoVillaba, Madrid; Road from Alpedrete to Moralzarzal M 608 Km 41 Collado Villalba Madrid Comunidad de Madrid Spain 28400"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria N","family":"Plana","sequence":"additional","affiliation":[{"name":"Clinical Biostatistics Unit, Ram\u00f3n y Cajal Hospital (IRYCIS), CIBER Epidemiology and Public Health (CIBERESP); Carretera de Colmenar Km 9.100 Madrid Spain 28034"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almudena","family":"A\u00f1ino Alba","sequence":"additional","affiliation":[{"name":"Servicio Madrile\u00f1o de Salud; Pharmacy Department; Alberto Palacios 22 Madrid Madrid Spain 28021"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"G\u00f3mez \u00c1lvarez","sequence":"additional","affiliation":[{"name":"Gerencia de Atenci\u00f3n Primaria, Servicio Madrile\u00f1o de Salud; Centro de Salud Villaamil; Calle de Villaamil, 19 Madrid Madrid Spain 28028"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Fernandez-Esteban","sequence":"additional","affiliation":[{"name":"Servicio Madrile\u00f1o de Salud; Servicio de Farmacia. Direcci\u00f3n Asistencial Centro. Gerencia de Atenci\u00f3n Primaria; Calle Alberto Palacios 22 Madrid Madrid Spain 28021"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Carlos","family":"Saiz","sequence":"additional","affiliation":[{"name":"Navarre Health Service; Drug Prescribing Service; Plaza de la Paz, s\/n, 7th floor Pamplona Navarre Spain 31002"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Martin-Carrillo","sequence":"additional","affiliation":[{"name":"Madrid Health Service; \"Colmenarejo\" Health Centre; C\/ Ca\u00f1ada de las Merinas n\u00ba 64 Colmenarejo Madrid Spain 28270"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d3scar","family":"Pinar L\u00f3pez","sequence":"additional","affiliation":[{"name":"Doce de Octubre University Hospital; Hospital Pharmacy Service; Avenida de C\u00f3rdoba, s\/n Madrid Madrid Spain 28041"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,11,26]]},"reference":[{"issue":"8","key":"10.1002\/14651858.CD009462.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"22b","DOI":"10.1016\/0002-9149(90)90437-6","article-title":"A multicenter comparison of lovastatin and probucol for treatment of severe primary hypercholesterolemia","volume":"66","author":"Davignon","year":"1990","journal-title":"American Journal of Cardiology"},{"issue":"2-3","key":"10.1002\/14651858.CD009462.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0021-9150(90)90114-X","article-title":"Efficacy and safety of pravastatin in patients with primary hypercholesterolemia. II. Once-daily versus twice-daily dosing","volume":"85","author":"Hunninghake","year":"1990","journal-title":"Atherosclerosis"},{"issue":"9","key":"10.1002\/14651858.CD009462.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.clinthera.2013.06.020","article-title":"Efficacy and safety of morning versus evening dose of controlled-release simvastatin tablets in patients with hyperlipidemia: a randomized, double-blind, multicenter phase III trial","volume":"35","author":"Kim","year":"2013 Sep","journal-title":"Clinical Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD009462.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF00315385","article-title":"Actual versus prescribed timing of lovastatin doses assessed by electronic compliance monitoring","volume":"45","author":"Kruse","year":"1993","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD009462.pub2-BIB0005|cit5","first-page":"131-51","article-title":"Clinical effect of fluvastatin (XU62-320) on hyperlipidemia: dose frequency study in a double-blind comparative method","volume":"11","author":"Nakaya","year":"1995","journal-title":"Rinsho Iyaku (Journal of Clinical Therapeutics and Medicines)"},{"issue":"4","key":"10.1002\/14651858.CD009462.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1161\/01.ATV.11.4.816","article-title":"Comparison between morning and evening doses of simvastatin in hyperlipidemic subjects. A double-blind comparative study","volume":"11","author":"Saito","year":"1991","journal-title":"Arteriosclerosis and Thrombosis"},{"issue":"4","key":"10.1002\/14651858.CD009462.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000093200","article-title":"Efficacy and safety of fluvastatin-extended release in hypercholesterolemic patients: morning administration is equivalent to evening administration","volume":"106","author":"Scharnagl","year":"2006","journal-title":"Cardiology"},{"issue":"Suppl 7","key":"10.1002\/14651858.CD009462.pub2-BIB0008|cit8","first-page":"S109","article-title":"Lipid lowering efficacy between morning and evening simvastatin treatment: a randomized double-blind study","volume":"93","author":"Tharavanij","year":"2010","journal-title":"Journal of the Medical Association of Thailand [Chotmaihet thangphaet]"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD009462.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2165\/00003495-200767001-00004","article-title":"Atorvastatin efficacy in the primary and secondary prevention of cardiovascular events","volume":"67","author":"Arca","year":"2007","journal-title":"Drugs"},{"issue":"7","key":"10.1002\/14651858.CD009462.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/j.1552-4604.1996.tb04224.x","article-title":"Pharmacodynamic effects and pharmacokinetics of atorvastatin after administration to normocholesterolemic subjects in the morning and evening","volume":"36","author":"Cilla","year":"1996","journal-title":"Journal of Clinical Pharmacology"},{"issue":"6a","key":"10.1002\/14651858.CD009462.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"37s","DOI":"10.1016\/0002-9343(94)90230-5","article-title":"Fluvastatin administration at bedtime versus with the evening meal: a multicenter comparison of bioavailability, safety, and efficacy","volume":"96","author":"Dujovne","year":"1994","journal-title":"The American Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD009462.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"429","DOI":"10.5152\/akd.2010.141","article-title":"Influence of statin therapy on circadian variation of acute myocardial infarction","volume":"10","author":"Erdogan","year":"2010","journal-title":"Anadolu Kardiyol Derg"},{"issue":"6","key":"10.1002\/14651858.CD009462.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"328","DOI":"10.5414\/CPP45328","article-title":"Time-of-intake (morning versus evening) of extended-release fluvastatin in hyperlipemic patients is without influence on the pharmacodynamics (mevalonic acid excretion) and pharmacokinetics","volume":"45","author":"Fauler","year":"2007","journal-title":"International Journal of Clinical Pharmacology and Therapeutics"},{"issue":"4b","key":"10.1002\/14651858.CD009462.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"26j","DOI":"10.1016\/S0002-9149(98)00434-2","article-title":"Clinical efficacy of cerivastatin: phase IIa dose-ranging and dose-scheduling studies","volume":"82","author":"Hunninghake","year":"1998","journal-title":"American Journal of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD009462.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/clpt.1986.185","article-title":"Comparative efficacy of once versus twice daily mevinolin in the therapy of familial hypercholesterolemia","volume":"40","author":"Illingworth","year":"1986","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"21","key":"10.1002\/14651858.CD009462.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1001\/archinte.1994.00420210087010","article-title":"Efficacy and safety of once-daily vs twice-daily dosing with fluvastatin, a synthetic reductase inhibitor, in primary hypercholesterolemia","volume":"154","author":"Insull","year":"1994","journal-title":"Archives of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD009462.pub2-BIB0017|cit17","first-page":"407","article-title":"The comparison of the effects of standard 20 mg atorvastatin daily and 20 mg atorvastatin every other day on serum LDL-cholesterol and high sensitive C-reactive protein levels","volume":"8","author":"Kele","year":"2008","journal-title":"Anadolu Kardiyoloji Dergisi [Anatolian Journal of Cardiology]"},{"issue":"7","key":"10.1002\/14651858.CD009462.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"784-6","DOI":"10.1016\/S0002-9149(02)02614-0","article-title":"Effect of morning versus evening intake of simvastatin on the serum cholesterol level in patients with coronary artery disease","volume":"90","author":"Lund","year":"2002","journal-title":"American Journal of Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD009462.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1046\/j.1365-2125.2002.01688.x","article-title":"Pharmacodynamic effects and pharmacokinetics of a new HMG-CoA reductase inhibitor, rosuvastatin, after morning or evening administration in healthy volunteers","volume":"54","author":"Martin","year":"2002","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD009462.pub2-BIB0020|cit20","first-page":"47","article-title":"Clinical evaluation of pravastatin (CS-514) in once daily therapy on hyperlipidemia: double-blind comparative study between once daily and twice daily therapy","volume":"19","author":"Matsuzawa","year":"1991","journal-title":"Rinsho Hyoka (Clinical Evaluation)"},{"issue":"5","key":"10.1002\/14651858.CD009462.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF00203778","article-title":"Effects of pravastatin on plasma and urinary mevalonate concentrations in subjects with familial hypercholesterolaemia: a comparison of morning and evening administration","volume":"49","author":"Nozaki","year":"1996","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"23","key":"10.1002\/14651858.CD009462.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.2146\/ajhp050072","article-title":"Effects of morning versus evening administration of atorvastatin in patients with hyperlipidemia","volume":"62","author":"Plakogiannis","year":"2005","journal-title":"American Journal of Health-System Pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists"},{"issue":"5","key":"10.1002\/14651858.CD009462.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/clpt.2009.100","article-title":"Population analyses of atorvastatin clearance in patients living in the community and in nursing homes","volume":"86","author":"Schwartz","year":"2009","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD009462.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/107424849700200102","article-title":"Cerivastatin, a new potent synthetic HMG Co-A reductase inhibitor: effect of 0.2 mg daily in subjects with primary hypercholesterolemia","volume":"2","author":"Stein","year":"1997","journal-title":"Journal of Cardiovascular Pharmacology and Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD009462.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00045391-199504000-00008","article-title":"Chronokinetics of pravastatin administered in the PM compared with AM dosing","volume":"2","author":"Triscari","year":"1995","journal-title":"American Journal of Therapeutics"},{"issue":"7418","key":"10.1002\/14651858.CD009462.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/bmj.327.7418.788","article-title":"Taking simvastatin in the morning compared with in the evening: randomised controlled trial","volume":"327","author":"Wallace","year":"2003","journal-title":"BMJ"},{"issue":"7-8","key":"10.1002\/14651858.CD009462.pub2-BIB0027|cit27","first-page":"841","article-title":"Comparison of effects of morning versus evening administration of ezetimibe\/simvastatin on serum cholesterol in patients with primary hypercholesterolemia. [Erratum appears in Annals of Pharmacotherapy 2011 Sep;45(9):1172]","volume":"45","author":"Yoon Hyung","year":"2011","journal-title":"Annals of Pharmacotherapy"},{"issue":"9","key":"10.1002\/14651858.CD009462.pub2-BIB0028|cit28","first-page":"1803-28","article-title":"Clinical study of pravastatin (CS-514) at once daily in hyperlipidemia: double-blind comparative study between morning and evening therapy","volume":"6","author":"Nakaya","year":"1990","journal-title":"Rinsho Iyaku (Journal of Clinical Therapeutics and Medicines)"},{"issue":"9493","key":"10.1002\/14651858.CD009462.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"issue":"9753","key":"10.1002\/14651858.CD009462.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"issue":"11","key":"10.1002\/14651858.CD009462.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/S0002-9149(97)00181-1","article-title":"Meta-analysis of the morning excess of acute myocardial infarction and sudden cardiac death","volume":"79","author":"Cohen","year":"1997","journal-title":"The American Journal of Cardiology"},{"issue":"20","key":"10.1002\/14651858.CD009462.pub2-BIB0032|cit32","first-page":"2569","article-title":"Biorhythms and chronotherapy in cardiovascular disease","volume":"51","author":"Cooke","year":"1994","journal-title":"American Journal of Hospital Pharmacy"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD009462.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1093\/ajhp\/55.suppl_3.S5","article-title":"Circadian variations in cardiovascular function and their relation to the occurrence and timing of cardiac events","volume":"55","author":"Cooke-Ariel","year":"1998","journal-title":"American Journal of Health-System Pharmacy"},{"key":"10.1002\/14651858.CD009462.pub2-BIB0034|cit34","unstructured":"Deeks JJ Higgins JPT Altman DG (editors) Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"20","key":"10.1002\/14651858.CD009462.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","article-title":"Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS\/TexCAPS. Air Force\/Texas Coronary Atherosclerosis Prevention Study","volume":"279","author":"Downs","year":"1998","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD009462.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/01.STR.29.5.992","article-title":"Circadian variation in the timing of stroke onset: a meta-analysis","volume":"29","author":"Elliott","year":"1998","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD009462.pub2-BIB0037|cit37","unstructured":"European Heart Network (EHN) Cardiovascular disease statistics\u00a02008 www.ehnheart.org\/cdv-statistics.html"},{"issue":"5","key":"10.1002\/14651858.CD009462.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1053\/j.gastro.2005.09.009","article-title":"Bile acid synthesis in humans has a rapid diurnal variation that is asynchronous with cholesterol synthesis","volume":"129","author":"Galman","year":"2005","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD009462.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jclinepi.2004.09.013","article-title":"Uncertainty method improved on best-worst case analysis in a binary meta-analysis","volume":"58","author":"Gamble","year":"2005","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD009462.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"GRADE Working Group","year":"2004","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009462.pub2-BIB0041|cit41","unstructured":"McMaster University (developed by Evidence Prime, Inc). Available from www.gradepro.org GRADEpro Guideline Development Tool 2015"},{"issue":"19","key":"10.1002\/14651858.CD009462.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1093\/eurheartj\/ehm316","article-title":"European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)","volume":"28","author":"Graham","year":"2007","journal-title":"European Heart Journal"},{"issue":"5","key":"10.1002\/14651858.CD009462.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/clc.4960180507","article-title":"Effect of simvastatin on Lp(a) concentrations","volume":"18","author":"Haffner","year":"1995","journal-title":"Clinical Cardiology"},{"key":"10.1002\/14651858.CD009462.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009462.pub2-BIB0045|cit45","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD009462.pub2-BIB0046|cit46","unstructured":"Higgins JPT Deeks JJ (editors) Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD009462.pub2-BIB0047|cit47","unstructured":"Higgins JPT Deeks JJ Altman DG (editors) Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD009462.pub2-BIB0048|cit48","unstructured":"Institute for Clinical Systems Improvement (ICSI) Lipid management in adults. Health Care Guideline 2009 www.icsi.org\/guidelines_and_more\/gl_os_prot\/cardiovascular\/lipid_management_3\/lipid_management_in_adults__4.html"},{"issue":"5","key":"10.1002\/14651858.CD009462.pub2-BIB0049|cit49","first-page":"594","article-title":"Morning peak in the incidence of myocardial infarction: experience in the ISIS-2 trial","volume":"13","author":"ISIS-2 (Second International Study of Infarct Survival) Collaborative Group","year":"1992","journal-title":"European Heart Journal"},{"issue":"4","key":"10.1002\/14651858.CD009462.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0022-2275(20)42835-4","article-title":"Evidence for diurnal periodicity in human cholesterol synthesis","volume":"31","author":"Jones","year":"1990","journal-title":"Journal of Lipid Research"},{"issue":"1","key":"10.1002\/14651858.CD009462.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-90-1-85","article-title":"Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study","volume":"90","author":"Kannel","year":"1979","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD009462.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/0002-8703(92)90288-7","article-title":"Efficacy of lipid profiles in prediction of coronary disease","volume":"124","author":"Kannel","year":"1992","journal-title":"American Heart Journal"},{"issue":"8195 pt 1","key":"10.1002\/14651858.CD009462.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0140-6736(80)90280-9","article-title":"Alpha lipoprotein (HDL) cholesterol in the serum and the risk of coronary heart disease and death","volume":"2","author":"Keys","year":"1980","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD009462.pub2-BIB0054|cit54","first-page":"297","article-title":"Circadian rhythms in cardiovascular diseases - arrhythmias","volume":"49","author":"Kozak","year":"2003","journal-title":"Vnitrni Lekarstvi"},{"issue":"4","key":"10.1002\/14651858.CD009462.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2165\/00129784-200303040-00006","article-title":"Reduction of serum LDL-C levels: a relationship to clinical benefits","volume":"3","author":"LaRosa","year":"2003","journal-title":"American Journal of Cardiovascular Drugs"},{"issue":"7404","key":"10.1002\/14651858.CD009462.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1136\/bmj.326.7404.1423","article-title":"Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis","volume":"326","author":"Law","year":"2003","journal-title":"BMJ (Clinical research ed)"},{"key":"10.1002\/14651858.CD009462.pub2-BIB0057|cit57","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"3","key":"10.1002\/14651858.CD009462.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00384-009-0838-4","article-title":"Chronomodulated chemotherapy versus conventional chemotherapy for advanced colorectal cancer: a meta-analysis of five randomised controlled trials","volume":"25","author":"Liao","year":"2010","journal-title":"International Journal of Colorectal Disease"},{"issue":"7","key":"10.1002\/14651858.CD009462.pub2-BIB0059|cit59","first-page":"e46","article-title":"Heart disease and stroke statistics - 2010 update: a report from the American Heart Association","volume":"121","author":"Lloyd-Jones","year":"2010","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD009462.pub2-BIB0060|cit60","unstructured":"Loke YK Price D Herxheimer A Chapter 14: Adverse effects. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"3","key":"10.1002\/14651858.CD009462.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jama.1984.03340270043026","article-title":"The Lipid Research Clinics Coronary Primary Prevention Trial results II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering","volume":"251","author":"LRC-CPPT","year":"1984","journal-title":"JAMA"},{"issue":"4","key":"10.1002\/14651858.CD009462.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/clpt.2009.306","article-title":"A model-based meta-analysis of the effect of latanoprost chronotherapy on the circadian intraocular pressure of patients with glaucoma or ocular hypertension","volume":"87","author":"Luu","year":"2010","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD009462.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000177040","article-title":"Circadian variation and triggers of cardiovascular disease","volume":"85 Suppl 2","author":"Muller","year":"1994","journal-title":"Cardiology"},{"issue":"25","key":"10.1002\/14651858.CD009462.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report","volume":"106","author":"National Cholesterol Education Program","year":"2002","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD009462.pub2-BIB0065|cit65","unstructured":"National Institute for Health and Clinical Excellence NICE clinical guideline 67: Lipid Modification. Cardiovascular risk assessment and the primary and secondary prevention of cardiovascular disease www.nice.org.uk\/nicemedia\/pdf\/CG67NICEguideline.pdf"},{"key":"10.1002\/14651858.CD009462.pub2-BIB0066|cit66","unstructured":"New Zealand Guidelines Group (NZGG) Assessment and management of cardiovascular risk www.nzgg.org.nz\/guidelines\/dsp_guideline_popup.cfm?guidelineCatID=3&guidelineID=35"},{"issue":"9","key":"10.1002\/14651858.CD009462.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1073\/pnas.79.9.3037","article-title":"Mevalonic acid in human plasma: relationship of concentration and circadian rhythm to cholesterol synthesis rates in man","volume":"79","author":"Parker","year":"1982","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"10.1002\/14651858.CD009462.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.atherosclerosissup.2004.08.027","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994","volume":"5","author":"Pedersen","year":"2004","journal-title":"Atherosclerosis. Supplements"},{"key":"10.1002\/14651858.CD009462.pub2-BIB0069|cit69","volume-title":"European Cardiovascular Disease Statistics","author":"Petersen","year":"2005"},{"issue":"1","key":"10.1002\/14651858.CD009462.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1345\/aph.1G659","article-title":"Optimal low-density lipoprotein cholesterol lowering - morning versus evening statin administration","volume":"41","author":"Plakogiannis","year":"2007","journal-title":"The Annals of Pharmacotherapy"},{"issue":"13","key":"10.1002\/14651858.CD009462.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1161\/CIRCULATIONAHA.109.192617","article-title":"AHA\/ACCF [corrected] 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation\/American Heart Association task force on performance measures (writing committee to develop performance measures for primary prevention of cardiovascular disease): developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association: endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research","volume":"120","author":"Redberg","year":"2009","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD009462.pub2-BIB0072|cit72","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan) 2014"},{"issue":"14","key":"10.1002\/14651858.CD009462.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators","volume":"335","author":"Sacks","year":"1996","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD009462.pub2-BIB0074|cit74","unstructured":"San Vicente R P\u00e9rez I Ibarra J Berraondo I Uribe F Garcia de Madinabeitia JU Clinical practice guide on lipid management as a cariovascular risk factor 2008 www.guiasalud.es\/GPC\/GPC_433_Lipidos_compl_cast.pdf"},{"issue":"6","key":"10.1002\/14651858.CD009462.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.lfs.2006.10.006","article-title":"Physiological and therapeutic factors affecting cholesterol metabolism: does a reciprocal relationship between cholesterol absorption and synthesis really exist?","volume":"80","author":"Santosa","year":"2007","journal-title":"Life Sciences"},{"issue":"20","key":"10.1002\/14651858.CD009462.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group","volume":"333","author":"Shepherd","year":"1995","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD009462.pub2-BIB0077|cit77","unstructured":"Scottish Intercollegiate Guidelines Network (SIGN) SIGN 97: Risk estimation and the prevention of cardiovascular disease. A National Clinical Guideline 2007 www.sign.ac.uk\/pdf\/sign97.pdf"},{"key":"10.1002\/14651858.CD009462.pub2-BIB0078|cit78","unstructured":"Smith MEB Lee NJ Haney E Carson S Drug class review: HMG-CoA reductase inhibitors (statins). Update 5 www.ohsu.edu\/drugeffectiveness\/reports\/final.cfm"},{"key":"10.1002\/14651858.CD009462.pub2-BIB0079|cit79","unstructured":"Stedman Stedman's Medical Dictionary www.drugs.com\/medical_dictionary.html"},{"key":"10.1002\/14651858.CD009462.pub2-BIB0080|cit80","unstructured":"Sterne JAC Egger M Moher D (editors) Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD009462.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63(25_PA)","author":"Stone","year":"2014","journal-title":"Journal of the American College of Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD009462.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1157\/13076152","article-title":"Chronobiology, chronotherapy and vascular risk","volume":"205","author":"S\u00e1nchez Merino","year":"2005","journal-title":"Revista Clinica Espa\u00f1ola"},{"key":"10.1002\/14651858.CD009462.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/eurheartj\/11.suppl_H.21","article-title":"Serum lipoproteins as risk factors: recent epidemiologic studies in individuals with and without prevalent cardiovascular disease","volume":"11 Suppl H","author":"Tyroler","year":"1990","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD009462.pub2-BIB0084|cit84","unstructured":"World Health Organization (WHO) Cardiovascular disease (CVDs) 2009 www.who.int\/mediacentre\/factsheets\/fs317\/en\/index.html"},{"key":"10.1002\/14651858.CD009462.pub2-BIB0085|cit85","unstructured":"World Health Organization Statistical Information System (WHOSIS) 2009 Statistical Information System www.who.int\/whosis\/en\/"},{"issue":"2. Art. No.: CD","key":"10.1002\/14651858.CD009462.pub2-BIB0086|cit86","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004184","article-title":"Chronotherapy versus conventional drug therapy for hypertension","author":"Zhao","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD009462.pub2-BIB0087|cit87","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009462","article-title":"Chronotherapy versus conventional statins therapy for the treatment of hyperlipidaemia","author":"Fernandes-Tabera","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD009462.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T04:47:21Z","timestamp":1635742041000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009462.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Heart Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,11,26]]},"references-count":87,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2016,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009462.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,26]]}}}